Page de couverture de S24:E3 – Evidence-Based Strategies for Individualizing CAR T-Cell Therapy in Patients With RRMM

S24:E3 – Evidence-Based Strategies for Individualizing CAR T-Cell Therapy in Patients With RRMM

S24:E3 – Evidence-Based Strategies for Individualizing CAR T-Cell Therapy in Patients With RRMM

Écouter gratuitement

Voir les détails du balado

À propos de cet audio

In this Journal Club episode, our Faculty, Dr. Joseph Mikhael and Dr. Krina Patel, discuss what clinicians need to know about optimizing treatment strategies for their patients with multiple myeloma. They explore approaches to bridging therapy to improve efficacy and reduce toxicity, evidence-based principles for sequencing B-cell maturation antigen (BCMA)-targeted agents, and how to navigate the challenge of prior BCMA exposure to improve patient outcomes. Visit https://suitehome.atpointofcare.com/library/2676.13/page/0?subdomain=myeloma to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.

Ce que les auditeurs disent de S24:E3 – Evidence-Based Strategies for Individualizing CAR T-Cell Therapy in Patients With RRMM

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.